Підписатись
Назарій Кобиляк
Назарій Кобиляк
Bogomolets National Medical University, department endocrinology
Підтверджена електронна адреса в nmu.kiev.ua
Назва
Посилання
Посилання
Рік
Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial
J Rosenstock, V Perkovic, OE Johansen, ME Cooper, SE Kahn, N Marx, ...
Jama 321 (1), 69-79, 2019
10682019
Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes
HC Gerstein, N Sattar, J Rosenstock, C Ramasundarahettige, R Pratley, ...
New England journal of medicine 385 (10), 896-907, 2021
3992021
Probiotics in prevention and treatment of obesity: a critical view
N Kobyliak, C Conte, G Cammarota, AP Haley, I Styriak, L Gaspar, ...
Nutrition & metabolism 13, 1-13, 2016
3742016
Triglyceride lowering with pemafibrate to reduce cardiovascular risk
A Das Pradhan, RJ Glynn, JC Fruchart, JG MacFadyen, ES Zaharris, ...
New England Journal of Medicine 387 (21), 1923-1934, 2022
2962022
A multi-strain probiotic reduces the fatty liver index, cytokines and aminotransferase levels in NAFLD patients: evidence from a randomized clinical trial
N Kobyliak, L Abenavoli, G Mykhalchyshyn, L Kononenko, L Boccuto, ...
2012018
Pathophysiological role of host microbiota in the development of obesity
N Kobyliak, O Virchenko, T Falalyeyeva
Nutrition journal 15, 1-12, 2015
1782015
Effect of alive probiotic on insulin resistance in type 2 diabetes patients: randomized clinical trial
N Kobyliak, T Falalyeyeva, G Mykhalchyshyn, D Kyriienko, ...
Diabetes & Metabolic Syndrome: Clinical Research & Reviews 12 (5), 617-624, 2018
1742018
Linagliptin effects on heart failure and related outcomes in individuals with type 2 diabetes mellitus at high cardiovascular and renal risk in CARMELINA
DK McGuire, JH Alexander, OE Johansen, V Perkovic, J Rosenstock, ...
Circulation 139 (3), 351-361, 2019
1652019
Global multi-stakeholder endorsement of the MAFLD definition
N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ...
The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022
1552022
Caffeine and cardiovascular diseases: critical review of current research
A Zulli, RM Smith, P Kubatka, J Novak, Y Uehara, H Loftus, T Qaradakhi, ...
European Journal of Nutrition, 1-13, 2016
1092016
Probiotics function and modulation of the immune system in allergic diseases
M Eslami, A Bahar, M Keikha, M Karbalaei, NM Kobyliak, B Yousefi
Allergologia et Immunopathologia 48 (6), 771-788, 2020
932020
Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3
L Abenavoli, M Masarone, V Peta, N Milic, N Kobyliak, S Rouabhia, ...
World journal of gastroenterology: WJG 20 (41), 15233, 2014
882014
Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a …
J Rosenstock, V Perkovic, JH Alexander, ME Cooper, N Marx, MJ Pencina, ...
Cardiovascular diabetology 17, 1-15, 2018
862018
Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study
N Kobyliak, L Abenavoli, T Falalyeyeva, G Mykhalchyshyn, L Boccuto, ...
852018
Obeticholic acid: a new era in the treatment of nonalcoholic fatty liver disease
L Abenavoli, T Falalyeyeva, L Boccuto, O Tsyryuk, N Kobyliak
Pharmaceuticals 11 (4), 104, 2018
792018
Crosstalk between gut microbiota and antidiabetic drug action
Y Kyriachenko, T Falalyeyeva, O Korotkyi, N Molochek, N Kobyliak
World journal of diabetes 10 (3), 154, 2019
722019
Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult …
O Savcheniuk, N Kobyliak, M Kondro, O Virchenko, T Falalyeyeva, ...
BMC complementary and alternative medicine 14, 1-17, 2014
692014
Antioxidative effects of cerium dioxide nanoparticles ameliorate age-related male infertility: optimistic results in rats and the review of clinical clues for integrative …
NM Kobyliak, TM Falalyeyeva, OG Kuryk, TV Beregova, PM Bodnar, ...
EPMA Journal 6, 1-22, 2015
682015
Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats
N Kobyliak, O Virchenko, T Falalyeyeva, M Kondro, T Beregova, P Bodnar, ...
Biomedicine & Pharmacotherapy 90, 608-614, 2017
672017
Effect of linagliptin on cognitive performance in patients with type 2 diabetes and cardiorenal comorbidities: the CARMELINA randomized trial
GJ Biessels, C Verhagen, J Janssen, E van den Berg, B Zinman, ...
Diabetes care 42 (10), 1930-1938, 2019
642019
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20